Caio Cesar Arruda da Silva
Caio Cesar Arruda da Silva has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- José Roberto da Silva Júnior
Faculdade Pernambucana de Saúde (FPS)
4 shared publications - Mozart Júlio Tabosa Sales
Instituto de Medicina Integral Professor Fernando Figueira
4 shared publications - Aline Priscila Rego de Carvalho
Secretaria Estadual de Saúde de Pernambuco, Brasil
2 shared publications - Amanda Carolina Félix Cavalcanti de Abreu
Secretaria de Saúde do Recife, Brasil
2 shared publications - Paulo Sávio Angeiras de Goes
Federal University of Pernambuco, Recife, Brazil
2 shared publications - Suely Arruda Vidal
Instituto de Medicina Integral Prof. Fernando Figueira, Brazil
2 shared publications
Latest Publications
- Open Access
- 2 January 2026
- Published by Editora Unijui in Revista Contexto & Saúde
- Vol. 26 (51) , e16883
Evaluation of the humoral immune response to primary and booster covid-19 vaccination
This study aimed to evaluate the efficacy of the primary and booster vaccination response against COVID-19. This prospective cohort study was conducted in the Archipelago of Fernando de Noronha (Pernambuco, Brazil). A total of 350 adults (≥18 years), with and without previous SARS-CoV-2 infection, were included. Data collection occurred between May 2020 and May 2022. Serum levels of anti-SARS-CoV-2 IgG were evaluated before vaccination (T0), after the primary vaccination schedule with homologous vaccines (CoronaVac or ChAdOx1 – AstraZeneca/Oxford-Fiocruz), and after the heterologous booster dose with BNT162b2 (Pfizer-BioNTech). Detection of IgG antibodies was performed using a chemiluminescent immunoassay. Data were analyzed using GraphPad Prism 9.0 and SPSS 18.0 software, applying the Mann-Whitney and Sidak tests for longitudinal comparisons (p < 0.05). Participants were divided into two groups according to previous SARS-CoV-2 infection: infected (G1; n = 81) and not infected (G2; n = 269). In both groups, anti-SARS-CoV-2 IgG levels significantly increased after the primary vaccination scheme compared with pre-vaccination levels (p < 0.05). In G1, anti-SARS-CoV-2 IgG levels reduced after an interval between 14 and 30 days. After the booster dose with BNT162b2, anti-SARS-CoV-2 IgG levels increased and kept high for 233 days after vaccination. The decline in antibody levels observed after the primary vaccination with two homologous doses reinforces the need for a heterologous booster dose to maintain the humoral immune response.
- 2 January 2026
- Published by Editora Unijui in Revista Contexto & Saúde
- Vol. 26 (51) , e16883
Open AccessEvaluation of the humoral immune response to primary and booster covid-19 vaccination
This study aimed to evaluate the efficacy of the primary and booster vaccination response against COVID-19. This prospective cohort study was conducted in the Archipelago of Fernando de Noronha (Pernambuco, Brazil). A total of 350 adults (≥18 years), with and without previous SARS-CoV-2 infection, were included. Data collection occurred between May 2020 and May 2022. Serum levels of anti-SARS-CoV-2 IgG were evaluated before vaccination (T0), after the primary vaccination schedule with homologous vaccines (CoronaVac or ChAdOx1 – AstraZeneca/Oxford-Fiocruz), and after the heterologous booster dose with BNT162b2 (Pfizer-BioNTech). Detection of IgG antibodies was performed using a chemiluminescent immunoassay. Data were analyzed using GraphPad Prism 9.0 and SPSS 18.0 software, applying the Mann-Whitney and Sidak tests for longitudinal comparisons (p < 0.05). Participants were divided into two groups according to previous SARS-CoV-2 infection: infected (G1; n = 81) and not infected (G2; n = 269). In both groups, anti-SARS-CoV-2 IgG levels significantly increased after the primary vaccination scheme compared with pre-vaccination levels (p < 0.05). In G1, anti-SARS-CoV-2 IgG levels reduced after an interval between 14 and 30 days. After the booster dose with BNT162b2, anti-SARS-CoV-2 IgG levels increased and kept high for 233 days after vaccination. The decline in antibody levels observed after the primary vaccination with two homologous doses reinforces the need for a heterologous booster dose to maintain the humoral immune response.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Cadernos de Saude Publica
- Vol. 40 (10) , e00115623
Programa Mais Médicos: caracterização da qualidade da atenção básica considerando o tipo de provimento médico
O objetivo deste estudo foi caracterizar a qualidade da atenção básica com base nas respostas de profissionais e usuários, focando no tipo de médico - inserido ou não no Programa Mais Médicos (PMM). Realizou-se um estudo transversal aplicando o Questionário de Fortalecimento da Atenção Básica a 149 médicos e 795 usuários em unidades básicas de saúde de Pernambuco, Brasil, de fevereiro a novembro de 2018. Neste estudo, foi utilizado o conceito de provimento do PMM no qual foi previsto a destinação do profissional médico para área de vulnerabilidade social. Os médicos foram divididos em três subgrupos: brasileiros não PMM, brasileiros PMM e cubanos PMM. Foram gerados escores médios a partir da perspectiva dos profissionais e dos usuários por meio de análise bivariada e multivariada dos subgrupos dos médicos com variáveis sociodemográficas, educacionais e atributos da atenção primária, considerando-se o nível de significância de 5%. Médicos cubanos do PMM apresentaram os maiores escores médios, especialmente no atributo orientação familiar e comunitária (7,19), seguido pelo subgrupo dos brasileiros do programa (4,74). A análise multivariada mostrou significância para médicos cubanos, sexo feminino e profissionais com residência médica. Entre os usuários, observou-se maior associação com a qualidade da atenção básica no subgrupo dos médicos cubanos, com exceção da longitudinalidade. Os resultados indicam a efetividade dos médicos cubanos do PMM na atenção básica, ressaltando a necessidade de focar na centralidade do usuário. Os achados reforçam a importância de utilizar instrumentos de avaliação precisos e abrangentes na gestão da saúde pública.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Cadernos de Saude Publica
- Vol. 40 (10) , e00115623
Open AccessPrograma Mais Médicos: caracterização da qualidade da atenção básica considerando o tipo de provimento médico
O objetivo deste estudo foi caracterizar a qualidade da atenção básica com base nas respostas de profissionais e usuários, focando no tipo de médico - inserido ou não no Programa Mais Médicos (PMM). Realizou-se um estudo transversal aplicando o Questionário de Fortalecimento da Atenção Básica a 149 médicos e 795 usuários em unidades básicas de saúde de Pernambuco, Brasil, de fevereiro a novembro de 2018. Neste estudo, foi utilizado o conceito de provimento do PMM no qual foi previsto a destinação do profissional médico para área de vulnerabilidade social. Os médicos foram divididos em três subgrupos: brasileiros não PMM, brasileiros PMM e cubanos PMM. Foram gerados escores médios a partir da perspectiva dos profissionais e dos usuários por meio de análise bivariada e multivariada dos subgrupos dos médicos com variáveis sociodemográficas, educacionais e atributos da atenção primária, considerando-se o nível de significância de 5%. Médicos cubanos do PMM apresentaram os maiores escores médios, especialmente no atributo orientação familiar e comunitária (7,19), seguido pelo subgrupo dos brasileiros do programa (4,74). A análise multivariada mostrou significância para médicos cubanos, sexo feminino e profissionais com residência médica. Entre os usuários, observou-se maior associação com a qualidade da atenção básica no subgrupo dos médicos cubanos, com exceção da longitudinalidade. Os resultados indicam a efetividade dos médicos cubanos do PMM na atenção básica, ressaltando a necessidade de focar na centralidade do usuário. Os achados reforçam a importância de utilizar instrumentos de avaliação precisos e abrangentes na gestão da saúde pública.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 29 (10) , e08722023
Development and validation of a questionnaire (QSPC-Q) for assessment of quality and strengthening of primary care in Brazil
The performance evaluation of services through instruments is relevant, as it can support thoughts, actions and political approaches to meet a social need. The objective of the article was to develop and validate the Quality and Strengthening of Primary Care Questionnaire (QSPC-Q) for professionals and users based on Starfield attributes and Donabedian pillars. A mixed sequential study was performed to develop the QSPC-Q. The test was applied to 149 doctors and 795 users of basic health units. Psychometric properties was assessed by testing internal consistency using Cronbach’s alpha and exploratory factor analysis. Reproducibility od scale was assessed using intraclass cognitive and test-retest correlation. The final version of the follow-up consisted of 45 items aimed at physicians (Cronbach’s alpha = 0.921) and 33 at users (Cronbach’s alpha = 0.86); the intraclass respiratory capacity was 0.88. An exploratory factor analysis identified 13 factors associated with the pattern components. A short version with 29 items for professionals was also elaborated. Professional QSPC-Q (short and braided versions) and user QSPC-Q were valid.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 29 (10) , e08722023
Open AccessDevelopment and validation of a questionnaire (QSPC-Q) for assessment of quality and strengthening of primary care in Brazil
The performance evaluation of services through instruments is relevant, as it can support thoughts, actions and political approaches to meet a social need. The objective of the article was to develop and validate the Quality and Strengthening of Primary Care Questionnaire (QSPC-Q) for professionals and users based on Starfield attributes and Donabedian pillars. A mixed sequential study was performed to develop the QSPC-Q. The test was applied to 149 doctors and 795 users of basic health units. Psychometric properties was assessed by testing internal consistency using Cronbach’s alpha and exploratory factor analysis. Reproducibility od scale was assessed using intraclass cognitive and test-retest correlation. The final version of the follow-up consisted of 45 items aimed at physicians (Cronbach’s alpha = 0.921) and 33 at users (Cronbach’s alpha = 0.86); the intraclass respiratory capacity was 0.88. An exploratory factor analysis identified 13 factors associated with the pattern components. A short version with 29 items for professionals was also elaborated. Professional QSPC-Q (short and braided versions) and user QSPC-Q were valid.
- Open Access
- 11 August 2023
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 49 (4) , e20230145
Risk factors for death and illness severity in vaccinated versus unvaccinated COVID-2019 inpatients: a retrospective cohort study
Objective: To determine the clinical profile of COVID-19 inpatients who were vaccinated prior to hospitalization and to compare the risk factors for death and the 28-day survival rate of between those inpatients vaccinated with one, two, or three doses and unvaccinated COVID-19 inpatients. Methods: This was a retrospective observational cohort study involving COVID-19 patients admitted to a referral hospital in the city of Recife, Brazil, between July of 2020 and June of 2022. Results: The sample comprised 1,921 inpatients, 996 of whom (50.8%) were vaccinated prior to hospitalization. After adjusting the mortality risk for vaccinated patients, those undergoing invasive mechanical ventilation (IMV) had the highest mortality risk (adjusted OR [aOR] = 7.4; 95% CI, 3.8-14.1; p < 0.001), followed by patients > 80 years of age (aOR = 7.3; 95% CI, 3.4-15.4; p < 0.001), and those needing vasopressors (aOR = 5.6; 95% CI, 2.9-10.9; p < 0.001). After adjusting the mortality risk for all patients, having received three vaccine doses (aOR = 0.06; 95% CI, 0.03-0.11; p < 0.001) was the most important protective factor against death. There were progressive benefits of vaccination, reducing the frequency of ICU admissions, use for IMV, and death (respectively, from 44.9%, 39.0% and 39.9% after the first dose to 16.7%, 6.2% and 4.4% after the third dose), as well as significant improvements in survival after each subsequent dose (p < 0.001). Conclusions: Vaccines were effective in reducing illness severity and death in this cohort of COVID-19 inpatients, and the administration of additional doses conferred them with accumulative vaccine protection.
- 11 August 2023
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 49 (4) , e20230145
Open AccessRisk factors for death and illness severity in vaccinated versus unvaccinated COVID-2019 inpatients: a retrospective cohort study
Objective: To determine the clinical profile of COVID-19 inpatients who were vaccinated prior to hospitalization and to compare the risk factors for death and the 28-day survival rate of between those inpatients vaccinated with one, two, or three doses and unvaccinated COVID-19 inpatients. Methods: This was a retrospective observational cohort study involving COVID-19 patients admitted to a referral hospital in the city of Recife, Brazil, between July of 2020 and June of 2022. Results: The sample comprised 1,921 inpatients, 996 of whom (50.8%) were vaccinated prior to hospitalization. After adjusting the mortality risk for vaccinated patients, those undergoing invasive mechanical ventilation (IMV) had the highest mortality risk (adjusted OR [aOR] = 7.4; 95% CI, 3.8-14.1; p < 0.001), followed by patients > 80 years of age (aOR = 7.3; 95% CI, 3.4-15.4; p < 0.001), and those needing vasopressors (aOR = 5.6; 95% CI, 2.9-10.9; p < 0.001). After adjusting the mortality risk for all patients, having received three vaccine doses (aOR = 0.06; 95% CI, 0.03-0.11; p < 0.001) was the most important protective factor against death. There were progressive benefits of vaccination, reducing the frequency of ICU admissions, use for IMV, and death (respectively, from 44.9%, 39.0% and 39.9% after the first dose to 16.7%, 6.2% and 4.4% after the third dose), as well as significant improvements in survival after each subsequent dose (p < 0.001). Conclusions: Vaccines were effective in reducing illness severity and death in this cohort of COVID-19 inpatients, and the administration of additional doses conferred them with accumulative vaccine protection.